The prognostic role of microsatellite instability, codon-specificKRAS, andBRAFmutations in colon cancer
- 25 June 2014
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (4), 451-457
- https://doi.org/10.1002/jso.23675
Abstract
Background This study aimed to establish a correlation between MSI, KRAS mutations, and BRAFV600E in colon cancer and to investigate the prognostic effect. Methods Colon cancer patients who underwent surgical intervention were enrolled. MSI status was identified by genotyping, and the mutational statuses of KRAS and BRAF were determined by MassARRAY, targeting 22 mutations. The clinicopathological differences and correlations between these factors were analyzed. Results Among 1,063 patients, tumors with MSI-H were significantly associated with BRAFV600E (P=0.001). KRAS and BRAF mutations were mutually exclusive (P=0.001). Patients with MSI-H tumors had significantly improved overall survival compared with patients that had microsatellite instability-low/stable (MSI-L/MSS) tumors (hazard ratio 0.686: 95% confidence interval: 0.479-1.162, P=0.040). In addition, the BRAFV600E mutation was a poor prognostic factor in tumors with MSI-L/MSS (P=0.020). KRAS mutations were not prognostic factors, but sub-group analysis demonstrated that mutations in KRAS codon 12 were associated with significantly worse survival than wild-type KRAS, mutations in KRAS codon 13, or mutations elsewhere. Conclusions MSI and the BRAFV600E mutation have a prognostic impact in colon cancer. Variable KRAS mutations may have different effects on colon cancers; further studies are needed to verify these results. J. Surg. Oncol. 2014; 110:451-457. (c) 2014 Wiley Periodicals, Inc.Funding Information
- Taipei Veterans General Hospital (V101E2-005, V102C-166)
This publication has 58 references indexed in Scilit:
- Epigenetics and colorectal cancerNature Reviews Gastroenterology & Hepatology, 2011
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerBritish Journal of Cancer, 2011
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology, 2010
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapyCancer Chemotherapy and Pharmacology, 2009
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerBritish Journal of Cancer, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerThe New England Journal of Medicine, 2009
- Transformation Efficiency of RasQ61 Mutants Linked to Structural Features of the Switch Regions in the Presence of RafStructure, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001